BDBM50039601 (4S,7R,13R,16S)-16-Acetylamino-7-carboxymethyl-13-(3-guanidino-propyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid::CHEMBL421348
SMILES: CC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CCCNC(N)=N)NC1=O)C(O)=O
InChI Key: InChIKey=HURPVXRLYUYEPQ-FDYHWXHSSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50039601 ((4S,7R,13R,16S)-16-Acetylamino-7-carboxymethyl-13-...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 680 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light . | J Med Chem 37: 2537-51 (1994) BindingDB Entry DOI: 10.7270/Q2N878VF | |||||||||||
More data for this Ligand-Target Pair |